CCL3 on CD8+ T cells was also predicted to interact with CCR1 or CCR5 on myeloid cells and CXCL13 on CD8+ T cells was predicted to interact with CXCR5 on B cells or ACKR4 on cancer-associated fibroblasts. This evidence concerns the gene CCR5 and cancer.